
Centre restricts stem cell therapy for autism to approved trials
The story in brief
The Union Ministry of Health and Family Welfare issued an advisory restricting stem-cell therapy for autism to approved trials. The advisory follows the Supreme Court’s January 30, 2026, judgment in a PIL filed by Mumbai-based Yas Charitable Trust. Families who approached the Supreme Court after experiencing the consequences of such treatment view the advisory as a long-awaited regulatory safeguard.